Literature DB >> 22178957

Natural isothiocyanates: genotoxic potential versus chemoprevention.

Carmela Fimognari1, Eleonora Turrini2, Lorenzo Ferruzzi2, Monia Lenzi2, Patrizia Hrelia2.   

Abstract

Isothiocyanates, occurring in many dietary cruciferous vegetables, show interesting chemopreventive activities against several chronic-degenerative diseases, including cancer, cardiovascular diseases, neurodegeneration, diabetes. The electrophilic carbon residue in the isothiocyanate moiety reacts with biological nucleophiles and modification of proteins is recognized as a key mechanism underlying the biological activity of isothiocyanates. The nuclear factor-erythroid-2-related factor 2 system, which orchestrates the expression of a wide array of antioxidant genes, plays a role in the protective effect of isothiocyanates against almost all the pathological conditions reported above. Recent emerging findings suggest a further common mechanism. Chronic inflammation plays a central role in many human diseases and isothiocyanates inhibit the activity of many inflammation components, suppress cyclooxygenase 2, and irreversibly inactivate the macrophage migration inhibitory factor. Due to their electrophilic reactivity, some isothiocyanates are able to form adducts with DNA and induce gene mutations and chromosomal aberrations. DNA damage has been demonstrated to be involved in the pathogenesis of various chronic-degenerative diseases of epidemiological relevance. Thus, the genotoxicity of the isothiocyanates should be carefully considered. In addition, the dose-response relationship for genotoxic compounds does not suggest evidence of a threshold. Thus, chemicals that are genotoxic pose a greater potential risk to humans than non-genotoxic compounds. Dietary consumption levels of isothiocyanates appear to be several orders of magnitude lower than the doses used in the genotoxicity studies and thus it is highly unlikely that such toxicities would occur in humans. However, the beneficial properties of isothiocyanates stimulated an increase of dietary supplements and functional foods with highly enriched isothiocyanate concentrations on the market. Whether such concentrations may exert a potential health risk cannot be excluded with certainty and an accurate evaluation of the toxicological profile of isothiocyanates should be prompted before any major increase in their consumption be recommended or their clinical use suggested.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178957     DOI: 10.1016/j.mrrev.2011.12.001

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  25 in total

1.  Differential modulation of dibenzo[def,p]chrysene transplacental carcinogenesis: maternal diets rich in indole-3-carbinol versus sulforaphane.

Authors:  Lyndsey E Shorey; Erin P Madeen; Lauren L Atwell; Emily Ho; Christiane V Löhr; Clifford B Pereira; Roderick H Dashwood; David E Williams
Journal:  Toxicol Appl Pharmacol       Date:  2013-04-06       Impact factor: 4.219

2.  HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates.

Authors:  Praveen Rajendran; Ariam I Kidane; Tian-Wei Yu; Wan-Mohaiza Dashwood; William H Bisson; Christiane V Löhr; Emily Ho; David E Williams; Roderick H Dashwood
Journal:  Epigenetics       Date:  2013-04-26       Impact factor: 4.528

3.  The isothiocyanate erucin abrogates telomerase in hepatocellular carcinoma cells in vitro and in an orthotopic xenograft tumour model of HCC.

Authors:  Corinna Herz; Anke Hertrampf; Stefan Zimmermann; Nadine Stetter; Meike Wagner; Claudia Kleinhans; Miriam Erlacher; Julia Schüler; Stefanie Platz; Sascha Rohn; Volker Mersch-Sundermann; Evelyn Lamy
Journal:  J Cell Mol Med       Date:  2014-09-25       Impact factor: 5.310

Review 4.  Cytotoxic and Antitumor Activity of Sulforaphane: The Role of Reactive Oxygen Species.

Authors:  Piero Sestili; Carmela Fimognari
Journal:  Biomed Res Int       Date:  2015-06-22       Impact factor: 3.411

5.  Pharmacokinetics, Tissue Distribution, and Anti-Lipogenic/Adipogenic Effects of Allyl-Isothiocyanate Metabolites.

Authors:  Yang-Ji Kim; Da-Hye Lee; Jiyun Ahn; Woo-Jae Chung; Young Jin Jang; Ki-Seung Seong; Jae-Hak Moon; Tae Youl Ha; Chang Hwa Jung
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

6.  Erucin, the major isothiocyanate in arugula (Eruca sativa), inhibits proliferation of MCF7 tumor cells by suppressing microtubule dynamics.

Authors:  Olga Azarenko; Mary Ann Jordan; Leslie Wilson
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

Review 7.  Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment.

Authors:  Huanjie Yang; Xin Chen; Kai Li; Hassan Cheaito; Qianqian Yang; Guojun Wu; Jinbao Liu; Q Ping Dou
Journal:  Semin Cancer Biol       Date:  2019-12-26       Impact factor: 15.707

8.  Diversity in global gene expression and morphology across a watercress (Nasturtium officinale R. Br.) germplasm collection: first steps to breeding.

Authors:  Adrienne C Payne; Graham J J Clarkson; Steve Rothwell; Gail Taylor
Journal:  Hortic Res       Date:  2015-07-08       Impact factor: 6.793

9.  Pterostilbene-isothiocyanate conjugate suppresses growth of prostate cancer cells irrespective of androgen receptor status.

Authors:  Kumar Nikhil; Shruti Sharan; Ajanta Chakraborty; Partha Roy
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

10.  Antileukemic activity of sulforaphane in primary blasts from patients affected by myelo- and lympho-proliferative disorders and in hypoxic conditions.

Authors:  Carmela Fimognari; Eleonora Turrini; Piero Sestili; Cinzia Calcabrini; Giovanni Carulli; Giulia Fontanelli; Martina Rousseau; Giorgio Cantelli-Forti; Patrizia Hrelia
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.